The system — also a continuous blood diagnostics system — aims to fill a key gap in the standard of care. Boston-based Admetsys designed it to automatically measure multiple blood analytes, including glucose, in real-time. It requires no patient blood loss.
From the measurement, it creates an adaptive, computational model of each patient’s metabolism. The system evolves with the patient condition, delivering precisely optimized insulin and dextrose treatments through multiple infusion channels.
Get the full story at our sister site, Drug Delivery Business News.